This symposium, presented by Cleveland Clinic’s Genomic Medicine Institute (GMI) and the Center for Personalized Genetic Healthcare (CPGH), will highlight cutting-edge research and advances in the diagnosis, management and treatment of hereditary cancer syndromes. Expert Cleveland Clinic and guest faculty will present case- and research-based presentations highlighting the integration of genetics and genomics into clinical practice.
Lucy Godley, MD, PhD, professor of medicine at the University of Chicago Medicine, will deliver the morning keynote address on hereditary hematologic malignancies. Other topics will include alternative approaches to genetic counseling, PTEN hamartoma tumor syndrome (PHTS), hereditary hematologic malignancies genetic counseling, Lynch syndrome screening (universal MSI/IHC vs somatic tumor testing) and vaccinations, gastric cancer risk in CDH1 carriers with/without gastric cancer family history and the role of upper endoscopy, immunotherapy, PARP inhibitors, and psychological adjustment to hereditary cancer syndromes.
7.75 AMA PRA Category 1 Credits™